Abstract
Mutations of BRCA2 in sporadic breast and ovarian carcinomas are exceedingly rare. This led to the suggestion that large genomic rearrangements could be involved. We performed Southern blots in genomic DNA from 130 primary breast cancers and 83 cancer cell lines (breast, ovarian, pancreatic and small cell lung carcinomas) and found no genomic rearrangements. These results suggest that a gene other than BRCA2 is the target of the frequent 13q12.3 allelic deletions in human cancers. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Cleton-Jansen AM, Collins N, Lakhani SR, Weissenbach J, Devilee P, Cornelisse CJ and Stratton MR (1995) Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13q12-q13. Br J Cancer 72: 1241–1244
Cooney KA, Wetzel JC, Merajver SD, Macoska JA, Singleton TP and Wojno KJ (1996) Distinct regions of allelic loss on 13q in prostate cancer. Cancer Research 56: 1142–1145
Foster KA, Harrington P, Kerr J, Russell P, DiCiccio RA, Scott IV, Jacobs I, Chevenix-Trench G, Ponder BAJ and Gayther SA (1996) Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer. Cancer Research 56: 3622–3625
Katagiri T, Nakamura Y and Miki Y (1996) Mutations in the BRCA2 gene in hepatocellular carcinoma. Cancer Res 56: 4575–4577
Kuroki T, Fujiwara Y, Nakamori S, Imaoka S, Kanematsu T and Nakamura Y (1995) Evidence for the presence of two tumour-suppressor genes for hepatocellular carcinoma on chromosome 13q. Br J Cancer 72: 383–385
Lancaster JM, Wooster R, Mangion J, Phelan CM, Coehran C, Grumbs C, Seal S, Barfoot R, Collins N, Bignell G, Patel S, Hamoudi R, Larsson C, Wiseman RW, Berchuck A, Iglehart JD, Marks JR, Ashworth A, Stratton MR and Futreal PA (1996) BRCA2 mutations in primary breast and ovarian cancers. Nature Genetics 13: 238–240
Lee, EH To H, Shew JY, Bookstein R, Scully P and Lee WH (1988) Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science 241: 218–221
Li C, Larsson C, Futreal A, Lancaster J, Phelan C, Aspenblad U, Sundelin B, Liu Y, Ekman P, Auer G and Bergerheim US (1998) Identification of two distinct deleted regions on chromosome 13 in prostate cancer. Oncogene 16: 481–487
Masuda H, Miller C, Koeffler HP, Battifora H and Cline MJ (1987) Rearrangements of the p53 gene in human osteogenic sarcomas. Proc Natl Acad Sci 84: 7716–7719
Miki Y, Katagiri T, Kasumi F, Yoshimoto T and Nakamura Y (1996) Mutation analysis in the BRCA2 gene in primary breast cancers. Nature Gen 13: 245–247
Nystrom-Lahti M, Kristo P, Nicolaides NC, Chang S-Y, Aaltonen LA, Moisio A-L, Jarvinen HJ, Mecklin JK, Kinzler KW, Vogelstein B, de La Chapelle A and Peltomaki P (1995) Founding mutations and Alu-mediated recombination in hereditary colon cancer. Nature Med 1: 1203–1206
Petrij-Bosch A, Peelen T, van Vliet M, van Eijk R, Olmer R, Drusedau M, Hogervorst FBL, Hageman S, Arts PJW, Ligtenberg MJL, Meijers-Heijboer H, Klijn JGM, Vasen HFA, Cornelisse CJ, van't Veer LJ, Bakker E, van Ommen G-JB and Devilee P (1997) BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nature Genetics 17: 341–345
Phelan CM, Lancaster JM, Tonin P, Gumbs C, Cochran C, Carter R, Ghadirian P, Perret C, Moslehi R, Dion F, Faucher MC, Dole K, Karimi S, Foulkes W, Lounis H, Warner E, Goss P, Anderson D, Larsson C, Narod SA and Futreal PA (1996) Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families [published erratum appears in Nat Genet 1996 Jul; 13(3):374]. Nat Genet 13: 120–122
Puget N, Serona-Sinilnikova, OM Stoppa-Lyonnet D, Audoynaud C, Pages S, Lynch HT, Goldgar D, Lenoir GM and Mazoyer S (1997a) An Alu-mediated 6-kb duplication in the BRCA1 gene: A new founder mutation?. Am J Hum Gen 64: 300–302
Puget N, Torchard D, Serona-Sinilnikova OM, Lynch HT, Feunteun J, Lenoir GM and Mazoyer S (1997b) A 1-kb Alu-mediated germline deletion removing BRCA1 exon 17. Cancer Res 57: 828–831
Rahman N and Stratton MR (1998) The genetics of breast cancer susceptibility. Annual Review of Genetics 32: 95–121
Ruggeri B, Zhang S-Y, Caamano J, DiRado M, Flynn SD and Klein-Szanto AJP (1992) Human pancreatic carcinomas and cell lines reveal frequent and multiple alterations in the p53 and Rb-1 tumour suppressor genes. Oncogene 7: 1503–1511
Schott DR, Chang JN, Deng G, Kurisu W, Kuo W-L, Gray J and Smith HS (1994) A candidate tumour suppressor gene in human breast cancers. Cancer Res 54: 1393–1396
Swensen J, Hoffman M, Skolnick MH and Neuhausen SL (1997) Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family. Hum Mol Gen 6: 1513–1517
Takahashi H, Chiu H-C, Bandera CA, Behbakht K, Liu PC, Couch FJ, Weber BL, LiVolsi VA, Furusato M, Rebane BA, Cardonick A, Benjamin I, Morgan MA, King SA, Mikuta JJ, Rubin SC and Boyd J (1996) Mutations of BRCA2 in ovarian carcinomas. Cancer Res 56: 2738–2741
Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S, Thorlacius S, Offit K, Stoppa-Lyonnet D, Belanger C, Bell R, Berry S, Bogden R, Chen Q, Davis T, Dumont M, Frye C, Hattier T, Jammulapati S, Janecki T, Jiang P, Kehrer R, Leblanc JF and Goldgar DE (1996) The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nature Gen 12: 333–337
Teng DH-F, Bogden R, Mitchell J, Baumgard M, Bell R, Berry S, Davis T, Ha PC, Kehrer R, Jammulapati S, Chen Q, Offit K, Skolnick MH, Swedlund B, Wong AKC and Kamb A (1996) Low incidence of Brca2 mutations in breast carcinoma and other cancers. Nature Gen 13: 241–244
van der Looij M, Cleton-Jansen A-M, van Eijk R, Morreau H, van Vliet M, Kuipers-Dijkshoorn N, Olah E, Cornelisse CJ and Devilee P (2000) A sporadic breast tumor with somatically acquired complex genomic rearrangement in. BRCA1 Genes Chromosomes Cancer 27: 295–302
Weber BHF, Brohm M, Stec I, Backe J and Caffier H (1996) A somatic truncating mutation in BRCA2 in a sporadic breast tumour. American Journal of Human Genetics 59: 962–964
Wijnen J, van der Klift H, Vasen H, Khan PM, Menko F, Tops C, Heijboer HM and Lindhout D (1998) MSH2 genomic deletions are a frequent cause of HNPCC. Nature Gen 20: 326–328
Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D, Fields P, Marshall G, Narod S, Lenoir GM, Lynch H, Feunteun J, Devilee P, Cornelisse CJ, Menko FH, Daly PA, Orniston W, McManus R, Pye C, Lewis CM, Cannon-Albright LA, Peto J, Ponder BAJ, Skolnick MH, Easton DF, Goldgar DE and Stratton MR (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12–13. Science 265: 2088–2090
Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G, Barfoot R, Hamoudi R, Patel S, Rice C, Biggs P, Hashim Y, Smith A, Connor F, Arason A, Gudmundsson J, Ficenec D, Kelsell D, Ford D, Tonin P, Bishop DT, Spurr NK, Ponder BAJ, Eeles R, Peto J, Devilee P, Cornelisse CJ, Lynch H, Narod S, Lenoir GM, Eglisson V, Barkadottir RB, Easton DF, Bentley DR, Futreal PA, Ashworth A and Stratton MR (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789–762
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Chin, SF., Wang, Q., Puisieux, A. et al. Absence of rearrangements in the BRCA2 gene in human cancers. Br J Cancer 84, 193–195 (2001). https://doi.org/10.1054/bjoc.2000.1577
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1577